Day: July 30, 2020

YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the second quarter 2020 and corporate updates, before market open on Tuesday, August 4, 2020.Company to Host Conference CallMembers of the Company’s leadership team will host a conference call to discuss financial results and corporate updates, including its launch of XHANCE®. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, August 4, 2020.To participate on the conference call, please dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until Tuesday, August 11,...

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2020. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.A live webcast of the call will be available on the Company’s website at www.siga.com under the ‘Events & Presentations’ tab in the Investor Relations section, or by clicking here. Participants may also access the call, by dialing 877-407-6184 for domestic callers or 201-389-0877 for international callers. Please log in approximately 5-10 minutes prior to the scheduled start time.A...

TUCSON, Ariz., July 30, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced three of its previously released Research Use Only (RUO) assays are now available for use with the Thermo Fisher Scientific Ion Torrent Ion S5 next-generation sequencing (NGS) platform.With the release of the HTG EdgeSeq Precision Immuno-Oncology Panel, the HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq Autoimmune Panel, the entire HTG RUO profiling assay menu is now available on both the Illumina and the Thermo Fisher Scientific NGS platforms.“We continue to see interest in our European market for our RUO profiling assays on both the Illumina and Thermo Fisher NGS platforms,” said Jean Claude Gerard, Senior Vice President, European...

DUBLIN, Ireland, July 30, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive Offer at Nabriva, will provide a company overview and business update at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12th, at 2:20p.m. ET.The presentation will be webcast live and may be accessed by visiting the “Investors” section of the Company’s website under the “Events and Presentations” tab at www.nabriva.com. A replay of the webcast will be available for 90 days.About Nabriva TherapeuticsNabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development...

ROCKVILLE, Md., July 30, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today provided an update on its corporate progress and reported financial results for the quarter ended June 30, 2020.“We are excited about the momentum we have built to date in 2020. We have presented promising initial clinical data at ASCO from the MGD013 and MGC018 programs. We have defined a potential registration path for flotetuzumab and we have received FDA clearance to initiate clinical testing of our novel antibody-drug conjugate targeting ADAM9 being co-developed with ImmunoGen. Furthermore, we were able to extend our cash runway into 2023,” said Scott Koenig, M.D., Ph.D., President...

PrologueIMPACT EXCEPTIONNEL DU COVID-19 EN FRANCE AU 2EME TRIMESTRE 2020BAISSE DU CA EN FRANCE DE 34,4% A 10,1 M€CROISSANCE HORS DE FRANCE DE 5,2% A 6,9 M€CROISSANCE DES ACTIVITES CLOUD DE 16,9%ACTIVITE EN BAISSE DE -22,6% AU 2EME TRIMESTRE 2020 A 16,98 M€Le groupe Prologue a enregistré, au 2ème trimestre 2020, un chiffre d’affaires de 16,98 M€ en baisse de -22,6%. L’impact du Covid-19 aura été de nature très différente selon les métiers et les régions.  IMPACT EXCEPTIONNEL DU COVID-19 EN FRANCE DANS LA FORMATIONAu cours du 2ème trimestre 2020, la formation a été de loin l’activité la plus impactée du groupe par la crise sanitaire liée au Covid-19, qui l’a contrainte à fermer l’ensemble de ses 35 centres en France du 16 mars jusqu’à début juin. Dans ce contexte exceptionnel, le groupe a réussi à mettre très rapidement en œuvre des solutions...

BEVERLY, Mass., July 30, 2020 (GLOBE NEWSWIRE) — ATN (NASDAQ: ATNI) announced today that its Chief Executive Officer, Michael T. Prior, and Chief Financial Officer, Justin D. Benincasa, are scheduled to present at the Oppenheimer Virtual 23rd Annual Technology, Internet & Communications Conference on August 11th, 2020. They will participate in a fireside chat at 4:20pm ET and will be available for one-on-one meetings throughout the day.For more information about ATN International, please visit www.atni.com. Presentations are posted in the Investor Relations section of the Company’s website at http://ir.atni.com/.About ATNATN International, Inc. (Nasdaq: ATNI), headquartered in Beverly, Massachusetts, invests in and operates communications, energy and technology businesses in the United States and internationally, including...

WILMINGTON, Del., July 30, 2020 (GLOBE NEWSWIRE) — WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in Piper Sandler’s Financial Services Virtual Conference, August 5 and 7, 2020. Rodger Levenson, WSFS’ Chairman, President and Chief Executive Officer, Dominic C. Canuso, WSFS’ Executive Vice President and Chief Financial Officer, and Steve Clark, Executive Vice President and Chief Commercial Banking Officer, will host one-on-one meetings with analysts and investors.Presentation Materials: WSFS will present the 2Q 2020 Investor Presentation, which is available on the Investor Relations section of WSFS’ website.About WSFS Financial CorporationWSFS Financial Corporation is a multi-billion-dollar financial services company. Its primary subsidiary, WSFS Bank, is the oldest and largest locally...

FONCIERE PARIS NORDRESULTATS 2019A Paris, le 30 juillet 2020Chiffres clefsPatrimoine (au coût amorti)17,8 Millions d’euros (y compris Restaurant Inter Entreprises)Résultat net consolidé(3 697) K€Cours de bourse au 29 juillet 2020 0,030 euroFaits marquants de l’exercice :–       PAMIER a sollicité de la part de ses deux banques, BNP PARIBAS et CREDIT FONCIER, un délai de paiement d’une durée de 5 mois assorti d’un échéancier mensuel prenant fin le 15 mai 2019, prévoyant un versement mensuel de 500 K€ pour chacun des prêteurs, devant permettre ainsi de solder les encours bancaires au terme convenu.Les échéances ont été respectées et ces deux prêts ont été soldés.–          La cession projetée du site fait toujours l’objet de négociations avec des acteurs de premier plan mais aucun engagement ferme n’a été signé à la date d’arrêté...